News

Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal

The paper features a comprehensive evaluation of data, including disease control rate, overall survival, immune activation, abscopal effects, tumor necrosis,...

Medical Care Technologies Inc. (OTC Pink:MDCE) Ranked #1 on InvestorHub Breakout Boards as Company Expands Across Technology and Collectibles Divisions

MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company...

error: Content is protected !!